Cargando…
A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database
Whether patients with medullary breast carcinoma (MBC) receive chemotherapy is controversial. Therefore, the aim of our study was to screen out patients with MBC who benefit from chemotherapy. We enrolled 618 consecutive patients with MBC from The Surveillance, Epidemiology, and End Results (SEER) d...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317966/ https://www.ncbi.nlm.nih.gov/pubmed/37400489 http://dx.doi.org/10.1038/s41598-023-37915-2 |